Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Liu C., Ginn HM., Dejnirattisai W., Supasa P., Wang B., Tuekprakhon A., Nutalai R., Zhou D., Mentzer AJ., Zhao Y., Duyvesteyn HME., López-Camacho C., Slon-Campos J., Walter TS., Skelly D., Johnson SA., Ritter TG., Mason C., Costa Clemens SA., Gomes Naveca F., Nascimento V., Nascimento F., Fernandes da Costa C., Resende PC., Pauvolid-Correa A., Siqueira MM., Dold C., Temperton N., Dong T., Pollard AJ., Knight JC., Crook D., Lambe T., Clutterbuck E., Bibi S., Flaxman A., Bittaye M., Belij-Rammerstorfer S., Gilbert SC., Malik T., Carroll MW., Klenerman P., Barnes E., Dunachie SJ., Baillie V., Serafin N., Ditse Z., Da Silva K., Paterson NG., Williams MA., Hall DR., Madhi S., Nunes MC., Goulder P., Fry EE., Mongkolsapaya J., Ren J., Stuart DI., Screaton GR.